Myeloid differentiation (MyD)/growth arrest DNA damage (GADD) genes in tumor suppression, immunity and inflammation

Leukemia

Volumn 16, Issue 4, 2002, Pages 527-541

  Liebermann, D A ^a   Hoffman, B ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; GADD45; Hematopoiesis; MyD116; MyD118; MyD88

Indexed keywords

GENE PRODUCT; INTERFERON REGULATORY FACTOR 1; ONCOPROTEIN; PROTEIN GADD; PROTEIN MYD; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR EGR 1; UNCLASSIFIED DRUG;

APOPTOSIS; BLOOD CELL; BONE MARROW CELL; CANCER INHIBITION; CELL CYCLE; CELL DIFFERENTIATION; CELL LINEAGE; CELL MATURATION; CELL SURVIVAL; CONTROLLED STUDY; DISEASE COURSE; DNA DAMAGE; DNA REPAIR; DRUG TARGETING; GENE INTERACTION; GROWTH INHIBITION; HOMEOSTASIS; HUMAN; HYPOXIA; IMMUNE RESPONSE; IMMUNOPATHOLOGY; INFLAMMATION; INFLAMMATORY DISEASE; ISCHEMIA; MALIGNANT NEOPLASTIC DISEASE; MICROORGANISM; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SEPTIC SHOCK; STRESS; TISSUE INJURY; TUMOR IMMUNITY;

ANIMALS; ANTIGENS, DIFFERENTIATION; APOPTOSIS; CELL CYCLE; DNA DAMAGE; GENE THERAPY; HUMANS; IMMUNITY; INFLAMMATION; NEOPLASMS;

EID: 0036238820     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2402477     Document Type: Review

References (226)

1. Complexity of the immediate early response of myeloid cells to terminal differentiation and growth arrest includes ICAM-1, Jun-B and histone variants
2. Interferon regulatory factor-1 is a myeloid differentiation primary response gene induced by IL6 and leukemia inhibitory factor: Role in growth inhibition
3. Dissection of the immediate early response of myeloid leukemia cells to terminal differentiation and growth inhibitory stimuli
4. The zinc finger transcription factor EGR-1 is essential for and restricts differentiation along the macrophage lineage
5. Sequence and expression of a cDNA encoding MyD118: A novel myeloid differentiation primary response gene induced by multiple cytokines
6. Sequence of MyD116 cDNA: A novel myeloid differentiation primary response gene induced by IL6
7. Nucleotide sequence and expression of a cDNA encoding MyD88, a novel myeloid differentiation primary response gene induced by IL6
8. Genotoxic-stress-response genes and growth-arrest genes: Gadd, MyD, and other genes induced by treatments eliciting growth arrest
9. Mammalian genes induced by radiation; activation of genes associated with growth control
10. The gadd and MyD genes define a novel set of mammalian genes encoding acidic proteins that synergistically suppress cell growth
11. Isolation of interleukin 2-induced immediate-early genes
12. CR6: A third member in the MyD118 and Gadd 45 gene family which functions in negative growth control
13. Ectopic expression of MyD118/Gadd45/CR6 (Gadd45beta/alpha/gamma) sensitizes neoplastic cells to genotoxic stress-induced apoptosis
14. The MyD118/Gadd4/CR6 gene family in negative growth control
15. A family of stress-inducible GADD45-like proteins mediate activation of the stress-responsive MTK1/MEKK4/MAPKKK
16. Induction of endogenous IFN-alpha and IFN-beta genes by a regulatory transcription factor, IRF-1
17. Absence of the type I IFN system in EC cells: Transcriptional activator (IRF-1) and repressor (IRF-2) genes are developmentally regulated
18. Regulated expression of a gene encoding a nuclear factor, IRF-1, that specifically binds to IFN-beta gene regulatory elements
19. Apoptosis in leukocytes
20. Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development
21. IRF family of transcription factors as regulators of host defense
22. Innate and acquired activation pathways in T cells
23. Multistage regulation of Th1-type immune responses by the transcription factor IRF-1
24. Interferon regulatory factor-1 is required for a T helper 1 immune response in vivo
25. Role of interferon regulatory factor-1 in the regulation of IL-18 production and activity
26. Cooperation of the tumour suppressors IRF-1 and p53 in response to DNA damage
27. Activation of multiple growth regulatory genes following inducible expression of IRF-1 or IRF/RelA fusion proteins
28. Identification of a novel transcriptional regulatory element common to the p53 and interferon regulatory factor 1 genes
29. Anti-oncogenic and oncogenic potentials of interferon regulatory factors-1 and -2
30. Loss of transcription factor IRF-1 affects tumor susceptibility in mice carrying the Ha-ras transgene or nullizygosity for p53
31. Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasia
32. Accelerated exon skipping of IRF-1 mRNA in human myelodysplasia/leukemia; a possible mechanism of tumor suppressor inactivation
33. Modulation of exon skipping and inclusion by heterogeneous nuclear ribonucleoprotein A1 and pre-mRNA splicing factor SF2/ASF
34. Common deleted region on the long arm of chro-mosome5 in esophageal carcinoma
35. Two distinct regions of deletion on the long arm of chromosome 5 in differentiated adenocarcinomas of the stomach
36. Functionally inactivating point mutation in the tumor-suppressor IRF-1 gene identified in human gastric cancer
37. Growth suppression of the hepatocellular carcinoma cell line Hepa1-6 by an activatable interferon regulatory factor-1 in mice
38. Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes
39. Cellular commitment to oncogene-induced transformation or apoptosis is dependent on the transcription factor IRF-1
40. An IRF-1-dependent pathway of DNA damage-induced apoptosis in mitogen-activated T lymphocytes
41. IFN-induces serine phosphorylation of Stat-1 in Ewing's sarcoma cells and mediates apoptosis via induction of IRF-1 and activation of caspase-7
42. Dual role of inflammatory stimuli in activation-induced cell death of mouse microglial cells: Initiation of two separate apoptotic pathways via induction of interferon regulatory factor-1 and caspase-11
43. Intersection of interferon and hypoxia signal transduction pathways in nitric oxide-induced tumor apoptosis
44. Interferon gamma (IFN gamma) and tumor necrosis factor alpha synergism in ME-180 cervical cancer cell apoptosis and necrosis. IFN gamma inhibits cytoprotective NF-kappa B through STAT1/IRF-1 pathways
45. IFN-gamma/TNF-alpha synergism as the final effector in autoimmune diabetes: A key role for STAT1/IFN regulatory factor-1 pathway in pancreatic beta cell death
46. Death receptors: Signaling and modulation
47. The IFN regulatory factor family participates in regulation of Fas ligand gene expression in T cells
48. Genome, v-jun encodes a nuclear protein with enhancer binding properties of AP-1
49. Oncogene jun encodes a sequence-specific transactivator similar to AP-1
50. A gene activated by growth factors is related to the oncogene v-jun
51. jun-D: A third member of the jun gene family
52. Protein, nucleotide A gene activated by growth factors is related to the oncogene v-jun
53. Proto-oncogene expression and dissection of the myeloid growth to differentiation developmental cascade
54. AP-1 (Fos/Jun) transcription factors in hematopoietic differentiation and apoptosis
55. Proto-oncogenes of the fos/jun family of transcription factors are positive regulators of myeloid differentiation
56. AP-1 in mouse development and tumorigenesis
57. Chronic myeloid leukemia with increased granulocyte progenitors in mice lacking junB expression in the myeloid lineage
58. fos-lacZ transgenic mice: Mapping sites of gene induction in the central nervous system
59. Continuous c-fos expression precedes programmed cell death in vivo
60. Programmed cell death in the absence of c-Fos and c-Jun
61. Altered gene expression in neurons during programmed cell death: Identification of c-jun as necessary for neuronal apoptosis
62. A c-Jun dominant negative mutant protects sympathetic neurons against programmed cell death
63. Withdrawal of survival factors results in activation of the JNK pathway in neuronal cells leading to Fas ligand induction and cell death
64. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis
65. Induction of apoptosis by the transcription factor c-Jun
66. Induction of apoptosis by c-Fos protein
67. The mammalian UV response mechanism of DNA damage induced gene expression
68. Response to adversity: Molecular control of gene activation following genotoxic stress
69. The regulation of AP-1 activity by mitogen-activated protein kinases
70. Mitogen-activated protein kinase cascades and regulation of gene expression
71. Requirements for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis
72. The mammalian UV response: C-Jun induction is required for exit from p53-imposed growth arrest
73. Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway
74. Jun-dependent CD95-L expression is a rate-limiting step in the induction of apoptosis by alkylating agents
75. Fos is an essential component of the mammalian UV response
76. DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-kappa B and AP-1
77. Stress-induced Fas ligand expression in T cells is mediated through a MEK kinase 1-regulated response element in the Fas ligand promoter
78. A nerve growth factor-induced gene encodes a possible transcription regulatory factor
79. A zinc finger-encoding gene coregulated with c-fos during growth and differentiation, and after cellular depolarization
80. A gene activated in mouse 3T3 cells by serum growth factors encodes a protein with 'zinc finger' sequences
81. The zinc finger transcription factor EGR-1 is essential for and restricts differentiation along the macrophage lineage
82. The zinc finger transcription factor Egr-1 potentiates macrophage differentiation of hematopoietic cells
83. Lineage specific regulation of hematopoiesis by Hox-B8 (Hox2.4): Inhibition of granulocyte differentiation and potentiation of monocytic differentiation
84. The zinc finger transcription factor Egr-1 activates macrophage differentiation in M1 myeloblastic leukemia cells
85. Early growth response gene 1 stimulates development of hematopoietic progenitor cells along the macrophage lineage at the expense of the granulocyte and erythroid lineages
86. Unimpaired macrophage differentiation and activation in mice lacking the zinc finger transcription factor NGFI-A (Egr1)
87. Suppression of growth and transformation and induction of apoptosis by EGR-1
88. Functional compensation by Egr4 in Egr1-dependent luteinizing hormone regulation and Leydig cell steroidogenesis
89. Ionizing radiation-inducible apoptosis in the absence of p53 linked to transcription factor EGR-1
90. Differential expression of Fas ligand in Th1 and Th2 cells is regulated by early growth response gene and NF-AT family members
91. Ionizing radiation down-regulates p53 protein in primary Egr-1-/- mouse embryonic fibroblast cells causing enhanced resistance to apoptosis
92. EGR-1, a UV-inducible gene in p53(-/-) mouse cells
93. Egr-1, a master switch coordinating upregulation of divergent gene families underlying ischemic stress
94. Interaction between alpha 5 beta 1 integrin and secreted fibronectin is involved in macrophage differentiation of human HL-60 myeloid leukemia cells
95. The transcription factor EGR-1 directly transactivates the fibronectin gene and enhances attachment of human glioblastoma cell line U251
96. The transcription factor EGR-1 suppresses transformation of human fibrosarcoma HT1080 cells by coordinated induction of transforming growth factor-beta1, fibronectin, and plasminogen activator inhibitor-1
97. Leukemia inhibitory factor and interleukin-6 trigger the same immediate-early response including tyrosine phosphorylation upon induction of myeloid leukemia differentiation
98. Dendritic-cell function in Toll-like receptor- and MyD88-knockout mice
99. The death domain: A module shared by proteins with diverse cellular functions
100. Molecular characterization and modular analysis of human MyD88
101. The death domain motif found in Fas (Apo-1) and TNF receptor is present in proteins involved in apoptosis and axonal guidance
102. Macrophage differentiation marker MyD88 is a member of the Toll/IL-1 receptor family
103. T1/ST2 signaling establishes it as a member of an expanding interleukin-1 receptor family
104. Interspecific comparisons reveal conserved features of the Drosophila Toll protein
105. A novel protein domain required for apoptosis. Mutational analysis of human Fas antigen
106. A novel domain within the 55 kDa TNF receptor signals cell death
107. The Toll gene of Drosophila, required for dorsal-ventral embryonic polarity, appears to encode a transmembrane protein
108. MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways
109. IL-1 Rrp is a novel receptor-like molecule similar to the type 1 interleukin-1 receptor and its homologues T1/ST2 and IL-1R AcP
110. Biologic basis for interleukin-1 in disease
111. Nuclear factor-kappaB: A pivotal transcription factor in chronic inflammatory diseases
112. NF-kappa B: Ten years after
113. The NF-kappa B and I kappa B proteins: New discoveries and insights
114. NF-kappa B and Rel proteins: Evolutionarily conserved mediators of immune responses
115. The NF-kappa B activation pathway: Its regulation and role in inflammation and cell survival
116. Molecular cloning and characterization of a second subunit of the interleukin 1 receptor complex
117. Recruitment of IRAK to the interleukin 1 receptor complex requires interleukin 1 receptor accessory protein
118. A critical role for interleukin-1 receptor accessory protein in interleukin-1 signaling
119. The interleukin-1 receptor accessory protein (IL-1 RAcP) is essential for IL-1-induced activation of interleukin-1 receptor-associated kinase (IRAK) and stress-activated protein kinases (SAP kinases)
120. IRAK: A kinase associated with the interleukin-1 receptor
121. TRAF6 is a signal transducer for interleukin-1
122. Tumor necrosis factor receptor-associated factor (TRAF) 5 and TRAF2 are involved in CD30-mediated NFkappaB activation
123. Induction of nuclear factor kappaB by the CD30 receptor is mediated by TRAF1 and TRAF2
124. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways
125. TRAF5, a novel tumor necrosis factor receptor-associated factor family protein, mediates CD40 signaling
126. TRAF5, an activator of NF-kappaB and putative signal transducer for the lymphotoxin-beta receptor
127. TRAF2-mediated activation of NF-kappa B by TNF receptor 2 and CD40
128. A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB
129. MAP3K-related kinase involved in NF-kappaB induction by TNF, CD95 and IL-1
130. IKK-1 and IKK-2: Cytokine-activated lkappaB kinases essential for NF-kappaB activation
131. Identification and characterization of an lkappaB kinase
132. Tumor necrosis factor (TNF)-mediated kinase cascades: Bifurcation of nuclear factor-kappaB and c-jun N-terminal kinase (JNK/SAPK) pathways at TNF receptor-associated factor 2
133. lkappaB kinase-beta: NF-kappaB activation and complex formation with lkappaB kinase-alpha and NIK
134. The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for lkappaB phosphorylation and NF-kappaB activation
135. Presence of a novel primary response gene ST2L, encoding a product highly similar to the interleukin 1 receptor type 1
136. Cloning of a cDNA encoding a novel interleukin-1 receptor related protein (IL 1R-rp2) 1996
137. IL-1 Rrp is a novel receptor-like molecule similar to the type I interleukin-1 receptor and its homologues T1/ST2 and IL-1R AcP
138. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity
139. The Arabidopsis downy mildew resistance gene RPP5 shares similarity to the toll and interleukin-1 receptors with N and L6
140. The Drosophila 18 wheeler is required for morphogenesis and has striking similarities to Toll
141. The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults
142. A conserved signal transduction pathway regulating the activity of the rel-like proteins dorsal and NF-kappa B
143. A conserved signaling pathway: The Drosophila toll-dorsal pathway
144. Functional interactions between the pelle kinase, Toll receptor, and tube suggest a mechanism for activation of dorsal
145. Domain mapping of tube, a protein essential for dorsoventral patterning of the Drosophila embryo
146. Pelle encodes a protein kinase required to establish dorsoventral polarity in the Drosophila embryo
147. Interaction of the pelle kinase with the membrane-associated protein tube is required for transduction of the dorsoventral signal in Drosophila embryos
148. Activation of the kinase Pelle by Tube in the dorsoventral signal transduction pathway of Drosophila embryo
149. MyD88, an adapter protein involved in interleukin-1 signaling
150. MyD88: An adapter that recruits IRAK to the IL-1 receptor complex
151. IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling
152. Toll-like receptors in the induction of the innate immune response
153. MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways
154. Unresponsiveness of MyD88-deficient mice to endotoxin
155. Structural basis for signal transduction by the Toll/interleukin-1 receptor domains
156. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function
157. The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B
158. TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex
159. Involvement of MACH, a novel of MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death
160. RIP and FADD: Two 'death domain'-containing proteins can induce apoptosis by convergent, but dissociable, pathways
161. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex
162. Ultrastructural distribution of the death-domain-containing MyD88 protein in HeLa cells
163. Dominant negative MyD88 proteins inhibit interleukin-1beta/interferon-gamma-mediated induction of nuclear factor kappa B-dependent nitrite production and apoptosis in beta cells
164. Lipopolysaccharide-induced activation of beta2-integrin function in macrophages requires Irak kinase activity, p38 mitogen-activated protein kinase, and the Rap1 GTPase
165. Subtraction hybridization identifies a transformation progression-associated gene PEG-3 with sequence homology to a growth arrest and DNA damage-inducible gene
166. Neurovirulence factor
167. Herpes simplex virus 1 gamma(1)34.5 gene function, which blocks the host response to infection, maps in the homologous domain of the genes expressed during growth arrest and DNA damage
168. The carboxyl terminus of the murine MyD116 gene substitutes for the corresponding domain of the gamma(1)34.5 gene of herpes simplex virus to preclude the premature shutoff of total protein synthesis in infected human cells
169. The gamma(1)34.5 protein of herpes simplex virus 1 complexes with protein phosphatase 1 alpha to dephosphorylate the alpha subunit of the eukaryotic translation initiation factor 2 and preclude the shutoff of double-stranded RNA-activated protein kinase
170. Identification of an African swine fever virus gene with similarity to a myeloid differentiation primary response gene and a neuro-virulence-associated gene of herpes simplex virus
171. Duplicated genes within the variable right end of the genome of a pathogenic isolate of African swine fever virus
172. Nucleotide sequence of a 55 kbp region from the right end of the genome of a pathogenic African swine fever virus isolate (Malawi LIL20/1)
173. An African swine fever virus virulence-associated gene NL-S with similarity to the herpes simplex virus ICP34.5 gene
174. Activation of Gadd34 by diverse apoptotic signals and suppression of its growth inhibitory effects by apoptotic inhibitors
175. An informatics approach identifying markers of chemosensitivity in human cancer cell lines
176. Feedback inhibition of the unfolded protein response by GADD34-mediated dephosphorylation of elF2alpha
177. Leukemic HRX fusion proteins inhibit GADD34-induced apoptosis and associate with the GADD34 and hSNF5/INI1 proteins
178. The herpes simplex virus virulence factor ICP34.5 and the cellular protein MyD116 complex with proliferating cell nuclear antigen through the 63-amino-acid domain conserved in ICP34.5, MyD116, and GADD34
179. Interaction between GADD34 and kinesin superfamily, KIF3A
180. Interaction between DNA-damage protein GADD34 and a new member of the Hsp40 family of heat shock proteins that is induced by a DNA-damaging reagent
181. Evidence for the interaction between Translin and GADD34 in mammalian cells
182. Cloning of a GADD34-like gene that interacts with the zinc-finger transcription factor which binds to the p21(WAF) promoter
183. Mammalian genes coordinately regulated by growth arrest signals and DNA-damaging agents
184. Induction by ionizing radiation of the gadd45 gene in cultured human cells: Lack of mediation by protein kinase C
185. WAF1/CIP1
186. MyD genes in negative growth control
187. The novel primary response gene MyD118 and the proto-oncogenes myb, and bcl-2 modulate transforming growth factor b1-induced apoptosis of myeloid leukemia cells
188. Immediate early up-regulation of bax expression by p53 but not TGFb1: A paradigm for distinct apoptotic pathways
189. Dissection of the genetic programs of p53 G1 growth arrest and apoptosis: Blocking p53-induced apoptosis unmasks G1 arrest
190. A mammalian cell cycle checkpoint utilizing p53 and gadd45 is defective in Ataxia-telangiectasia
191. Gadd45 is not required for activation of c-jun N-terminal kinase or p38 during acute stress
192. Stress-induced JNK activation is independent of Gadd45 induction
193. Genomic instability in Gadd45a-deficient mice
194. Protein interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen
195. p53-mediated DNA repair responses to UV radiation: Studies of mouse cells lacking p53, p21, and/or gadd45 genes
196. Characterization of MyD118, Gadd45, and PCNA interacting domains: PCNA impedes MyD/Gadd mediated negative growth control
197. Induction of GADD45 and JNK/SAPK-dependent apoptosis following inducible expression of BRCA1
198. Interaction of CR6 (GADD45gamma) with proliferating cell nuclear antigen (PCNA) impedes negative growth control
199. Antisense GADD45 expression results in decreased DNA repair and sensitizes cells to UV-irradiation or cisplatin
200. GADD45 induction of a G2/M cell cycle checkpoint
201. GADD45 proteins are cdc2/cyclinB1 kinase inhibitors with a role in G2/M cell cycle arrest
202. Functional link of BRCA1 and ataxia telangiectasia gene product in DNA damage response
203. Molecular cloning of rat GADD45gamma, gene induction and its role during neuronal cell death
204. Oligomerization of human Gadd45a protein
205. Mechanisms of DNA excision repair
206. Proliferating cell nuclear antigen: More than a clamp for DNA polymerases
207. Protein-PCNA interactions: A DNA-scanning mechanism?
208. The tumor suppressor candidate p33(ING1) mediates repair of UV-damaged DNA
209. Gadd45, a p53-responsive stress protein, modifies DNA accessibility on damaged chromatin
210. Association with Cdc2 and inhibition of Cdc2/Cyclin B1 kinase activity by the p53-regulated protein Gadd45
211. The GADD45 inhibition of Cdc2 kinase correlates with GADD45-mediated growth suppression
212. Identification of a functional domain in a Gadd-45-mediated G2/M checkpoint
213. Mammalian G1 and G2 phase checkpoints
214. Cell cycle checkpoints: Preventing an identity crisis
215. Proliferating cell nuclear antigen and p21 are components of multiple cell cycle kinase complexes
216. p21 is a universal inhibitor of cyclin kinases
217. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1
218. WAF1, a potential mediator of p53 tumor suppression
219. Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control
220. Cooperative effect of genes controlling the G(2)/M checkpoint
221. IL-18-stimulated GADD45 beta required in cytokine-induced, but not TCR-induced, IFN-gamma production
222. GADD45gamma mediates the activation of the p38 and JNK MAP kinase pathways and cytokine production in effector TH1 cells
223. The hallmarks of cancer
224. Leukemia and the disruption of normal hematopoiesis
225. Origins of human cancer revisited